This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on June 11, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Notice of Intent to Sole Source for 10X Genomics, Inc. Reagents Department (CCMD)

Closed

25-007587Federal

Submission Closed06/21/2025, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

SLED

First To Know Syphilis Tests and Controls Sets

Solicitation # QQ-130085

The Virginia Department of Health is soliciting quotes for First To Know Syphilis Tests and Controls manufactured by NowDiagnostics. The procurement includes 241 units of the Syphilis test kits (Item 8057-1-12), 145 units of the Convenience Pack (Item 8057-25-CP), and Non-assayed Syphilis Control Sets (Item 457.012). The contract is structured with four one-year renewal options, and the desired delivery time is 14 calendar days after receipt of order to a location in Henrico, Virginia. Bidders must provide a certified test report from a recognized laboratory and submit all proposals through the eVA portal. Award priority is given to DSBSD-certified micro and small businesses, including women-owned and minority-owned firms, provided the pricing is determined to be fair and reasonable. Proposals must remain valid for 90 days, and contractors are required to maintain specific insurance coverages authorized by the Virginia State Corporation Commission. Key technical requirements include the provision of Material Safety Data Sheets and adherence to strict storage protocols for control sets, which must be refrigerated at 2–8°C and not frozen. Payment is contingent upon the completion of installation, testing, and acceptance by the agency, with a standard payment term of 30 days.

Virginia Department of Health

POSTED

DEADLINE

Certified Industrial Wastewater Laboratory TestingThis subcontract opportunity is for certified industrial wastewater laboratory testing to support prime contractors on Department of Veterans Affairs Medical Center projects located in Huntington, West Virginia. The selected provider will be responsible for analyzing wastewater samples for Total Phenolics, Oil and Grease, Flashpoint, Acrolein, and a full list of Volatile Organic Compounds. All testing must be conducted using EPA analytical procedures as specified in 40 CFR Part 136, and the provider must deliver formal certified laboratory analysis reports. To be eligible, the contractor must hold a valid State of West Virginia certification for wastewater testing and possess specialized instrumentation required for VOC detection. This requirement falls under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 5. Interested parties should note the response deadline of November 16, 2026.

245-NETWORK Contract Office 5 (36C245)

POSTED

DEADLINE

Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.

Solicitation # 36C26027Q0058

The Department of Veterans Affairs, through Network Contracting Office 20, is seeking a comprehensive histology staining workflow system for the Puget Sound Health Care System in Seattle, Washington. The required system must include two immunohistochemistry and two in-situ hybridization immunostainers, two special stainers, and an integrated specimen tracking system to ensure patient safety, maintain a chain of custody, and monitor productivity. The workflow components must be fully automated, communicate with one another, and maintain compatibility with Data Innovations middleware as well as VISTA, Cerner, and any future electronic health record systems acquired by the VA. The contract follows a Cost Per Reportable Result pricing model and spans a base year from February 1, 2027, to January 31, 2028, with four subsequent one-year option periods extending through January 31, 2032. Technical requirements specify that the immunostainers must perform 100% of tests listed in the provided specifications and support simultaneous IHC, ISH, and Direct Immunofluorescence staining. Equipment must support Code 39 and Code 128 barcodes, include a safe hazardous waste removal system, and be provided with an uninterruptible power supply capable of supporting a 15-minute controlled shutdown. The contractor is responsible for the delivery, installation, and removal of equipment at no additional charge and must guarantee a minimum equipment uptime of 98%. Performance and method validation must adhere to CLSI guidelines and College of American Pathologists standards. Additionally, the contractor must comply with strict federal and VA information security directives, including those regarding data confidentiality and media sanitization. Emergency supply orders must be fulfilled within 24 hours of a verbal request, providing enough consumables for one week of normal operation.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Solicitation # HT942627QE003

The Army Medical Resources Acquisition Activity is soliciting a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1. To maintain FDA approval and operational requirements, the contractor must provide original manufacturer-supplied consumables, as no generic substitutes are available. Required supplies include Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, and ACD-A Solution. The contract is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS code 325413. The BPA features a cumulative ceiling not to exceed 350,000 dollars over a 60-month ordering period, with individual call orders typically having a 12-month period of performance. Award will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as either acceptable or unacceptable. Offerors must submit a two-volume quote by October 29, 2026, using the mandatory Exhibit A Pricing Sheet. Delivery is FOB Destination to Fort Sam Houston, Texas, and invoicing must be processed through the Wide Area WorkFlow system.

Army Medical Resources Acq Activity

POSTED

DEADLINE

6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES

Solicitation # 36C26227Q0046

The Department of Veterans Affairs, Network Contracting Office 22, is conducting a sources sought notice for the procurement of FDA approved reagents, supplies, consumables, and quality control materials for Werfen Hemochron Signature Elite instruments. This requirement supports the Pathology and Laboratory Medicine Service at the Southern Arizona VA Health Care System in Tucson, Arizona. The contract structure includes a base year from January 1, 2027, to December 31, 2028, followed by four subsequent option years extending through December 31, 2032. The selected contractor must provide 24/7 technical and product support at no additional cost and ensure all items are fully compatible with existing instrumentation without requiring workflow changes or retraining. Key operational requirements include strict adherence to manufacturer specifications for packaging and temperature control during transport. All supplied materials must maintain a minimum shelf life of 90 days, and shipments must clearly list lot numbers and expiration dates. Standard orders are required to be delivered within four working days, while emergency deliveries for defective or temperature-compromised items must be completed within 24 hours of a verbal order. This procurement is conducted as a brand name or equal acquisition under FAR 52.211-6. Interested respondents must provide their business size status, SAM.gov identifiers, and evidence of compliance with the Buy American Act and the Non-Manufacturer Rule.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Solicitation # 2139989

The New York State Office of Mental Health, specifically for the Nathan S. Kline Institute in Rockland, has established a single-source procurement exemption to add drug abuse testing commodities to an existing contract. This action integrates tests previously purchased on a discretionary basis, adding a total of 185,000.00 dollars over three years, which averages 61,500.00 dollars annually. The procurement includes specific laboratory calibrators and controls, such as Syva Creatinine Validity Calibrators in various concentrations, Syva Validity Negative Calibrators, and EMIT Calibrators/Controls at levels 2 and 5. The contract term is effective from May 1, 2024, through April 30, 2029, with the agency planning to re-procure these services around the fall of 2028. Ron Foster, Contract Management Specialist 2, serves as the primary point of contact for this agreement. This procurement was processed as an exemption from advertising to ensure the necessary testing materials are formally incorporated into the agency's contractual framework.

NYS Office of Mental Health

POSTED

DEADLINE

Cepheid Reagents & Supplies for GeneXpert Testing Platform

Solicitation # 2140004

The State University of New York, specifically SUNY Stony Brook University Hospital, has issued solicitation number 2140004 for the procurement of Cepheid Reagents and Supplies for the GeneXpert Testing Platform. This procurement is categorized under Medical and Health Care Commodities and is designated as a sole or single source procurement exempt from advertising. The request was formally approved by the Office of the State Comptroller on October 14, 2026, under NYS Contract Reporter Exemption Request SNY01-0004719-3320215 (CRER-0469C). The contract term is established from October 13, 2025, through October 12, 2027, with the place of performance located at Stony Brook University Hospital state-wide. The primary point of contact for this action is Zhong Yi Hu. The notice was posted on October 16, 2026, with an advertisement end date of October 23, 2026. No specific contract value or pricing details were provided in the documentation.

State University of New York (SUNY)

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-0714

Solicitation SPE2DS-27-T-0714 is issued by the Defense Logistics Agency for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2 and 30 degrees Celsius and must have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of order, with the FOB and inspection/acceptance points set to destination. The contractor must adhere to Medical Marking Standard No. 1 for all labeling, ensuring the inclusion of the contract or lot number and the manufacture, expiration, or retest date. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with DLA packaging requirements and MIL-STD-2073-1E. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American and Balance of Payments Program. The solicitation is categorized under NAICS code 325413 and incorporates various FAR and DFARS clauses regarding cybersecurity, safeguarding covered defense information, and the HUBZone price evaluation preference.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Antibody Identification Panel CellsThis subcontract involves the manufacture and delivery of antibody identification panel cells for prime contractors supporting Department of Veterans Affairs Network Contract Office 20 medical supply projects. These red blood cell reagents are critical for matching donated blood products to recipients within Surgery, Oncology, Emergency, and Medical Units, with shipments specifically destined for the Boise VA Medical Center. The provider must maintain strict compliance with clinical standards and hold Federal Supply Schedule status under Group 66 III Cat 605-2A. Operating under NAICS code 325413, the contract is managed by the Department of Veterans Affairs with performance associated with the Vancouver area.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Supply of Quality Control Check CellsThis subcontract involves the manufacture and delivery of specialized red blood cell quality control check cells for the Department of Veterans Affairs Network Contract Office 20. These reagents are critical for validating patient testing within the Transfusion Services Department and are delivered specifically to the Boise VA Medical Center. The provider must maintain strict quality control standards and hold Federal Supply Schedule status under Group 66 III Cat 605-2A. Operating under NAICS code 325413, the contract ensures that prime contractors on medical supply projects have the necessary materials to maintain clinical accuracy and regulatory compliance.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Q301--VA Boise, Idaho - Blood Bank Reagents Requirement

Solicitation # 36C26027Q0082

The Department of Veterans Affairs, through Network Contracting Office 20, has issued a pre-solicitation notice for the procurement of red blood cell reagents to support the Transfusion Services Department at the Boise, Idaho VA Medical Center. This requirement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing. The scope of work involves the supply of quality control check cells and antibody identification panel cells that adhere to strict quality control and compliance standards for patient testing. These reagents are critical for matching donated blood products to recipients in various hospital departments, including Surgery, Oncology, Emergency, and Medical Units. This notice is intended for market research and planning purposes and does not constitute a formal Request for Quotation or a commitment to contract. Interested parties must submit a response by October 26, 2026, at 16:00 PT to Contract Specialist Andrew O'Neal. Required submissions include company contact information, DUNS number, business size and socioeconomic status, a statement regarding Federal Supply Schedule status under Group 66 III Cat 605-2A, and a capability statement not exceeding three pages demonstrating the necessary resources, personnel, and experience to fulfill the requirement.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

KKH_KRFP261018_Medsupplies_Detection of DNA of BV and CV associated pathogens and TV kit with Free on Loan Equipment

Solicitation # Doc2439781197

KK Women’s and Children’s Hospital, through contracting agent ALPS Pte Ltd, is seeking proposals for the supply of detection kits for DNA of BV and CV associated pathogens and TV, including free on loan equipment. This term contract spans an initial five years with an option to extend for an additional three years. Eligible participants must be locally registered companies, and those providing medical devices must hold GDPMDS certification and ensure all devices are registered with the Health Science Authority of Singapore. The scope of supply includes delivery for consumables, as well as delivery, installation, integration, testing, and commissioning for any equipment provided. Interested vendors must submit their entire response via Ariba Sourcing between October 16, 2026, and October 30, 2026, at 3:00pm Singapore Time. Submissions through other channels may lead to disqualification, and suppliers are encouraged to use generic company email addresses for all event notifications.

ALPS Pte. Ltd.

POSTED

6 days ago

DEADLINE

in 9 days

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health - Cc

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedJun 11

Presolicitation

Response DeadlineJun 21

Deadline has passed

Submission Closed

06/21/2025, 07:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc

Office AddressBETHESDA, MD, 20892, USA

Contacts

Tasha Lowe

contact@example.gov

+1 (555) 000-0000

Full Description

Notice of Intent to Sole Source for 10X Genomics, Inc. Reagents Department (CCMD) Product Service Code: 6550 NAICS Code: 325413 Place of Performance: Bethesda, MD 20892 POTS: 25-007587 Description This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested. The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department (CCMD) intends to award a firm fixed price Purchase Order to 10X Genomics, Inc, located in Pleasanton, California 94588-3260 on a sole source basis to provide 10X Genomics reagents. The Critical Care Medicine Department is currently working on a project investigating the impact of SARS-CoV-2 infection on human brain tissues and cerebral organoid tissues at the single-cell level. The study utilizes 10X Genomics Dual Index TS Set A 96 rxn Kits, GEM-X Flex Sample Preparation v2 Kits, GEM-X Flex Gene Expression Chip, 4 chips kits, and GEM-X Flex Gene Expression Human 4 samples. These proprietary kits contain specialized reagents designed for the isolation and amplification of uniquely barcoded ribonucleic acid (RNA). The 10X Genomics platform uses microfluidics to separate individual cells into an emulsion with single gel beads and labels the RNA from each cell with a unique barcode for partitioning into libraries for sequencing. The Critical Care Medicine Department has independently modified and validated the recommended protocols provided by 10X Genomics to be compliant with - Biosafety Level 3 (BSL-3 requirements). There are no substitutions of equipment or reagents for this study and used under the existing protocols. Any change of equipment or reagents would cause a stoppage of work, and the substitutions would have to undergo a re-validation process that could take up to one year or more. This ultimately would negatively impact patient care by causing a delay and stoppage of work that would impact patient care and the research process. 10X Genomics, Inc kits are proprietary and are the only approved kits to be used in this research project. 10X Genomics is the sole manufacturer of the platform and single cell sequencing reagents. The below items are required for this action: Description/Product Code/Quantity: Dual Index Kit TS Set A, 96 rxn / Product Code: 1000251 / QTY: 1 GEM-X Flex Sample Preparation v2 Kit / Product Code: 1000781 / QTY: 1 GEM-X Flex Gene Expression Chip Kit, 4 chips / Product Code: 1000791 / QTY: 1 GEM-X Flex Gene Expression Human, 4 samples / Product Code: 1000792 / QTY: 4 This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested Parties: Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Comments: Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe Contract Specialist, lowet2@mail.nih.gov by the due date June 21, 2025, (3:00 pm EST) and time marked in this notice.